Mark E. Anderson MD, PhD, FAHA

In 2009-14, Dr. Anderson was the Francois M. Abboud Chair of Internal Medicine and the chairman and executive officer for the Department of Internal Medicine at the University of Iowa. He also served as director of the Francois M. Abboud Cardiovascular Research Center.

Before Iowa, Dr. Anderson was the Betty and Jack Bailey Professor of Medicine at Vanderbilt University in Nashville, Tennessee, where he served in multiple capacities, including director of the Electrophysiology and Cardiovascular Research Fellowship programs, Clinical Arrhythmia Service, and on the Vanderbilt Physician-Scientist Program Selection Committee.

He received a bachelor’s degree in biology from Macalester College in St. Paul, Minnesota and his MD and PhD in physiology from the University of Minnesota. He did an internal medicine residency and fellowships in cardiology and clinical cardiac electrophysiology at Stanford University.

Dr. Anderson’s research focuses on the mechanisms that cause heart failure and arrhythmias. He is widely recognized as an international expert in defining the role of calmodulin kinase II (CaMKII) regulation in heart failure and arrhythmias. He’s published more than 200 peer-reviewed papers and is co-founder of Allosteros Therapeutics, a biotech aiming to develop CaMKII inhibitor drugs.

Dr. Anderson is an elected member of the American Society for Clinical Investigation, National Academy of Medicine, Association of American Physicians and the American Clinical and Climatological Association. He is vice president of the Fondation Leducq Scientific Advisory Committee, associate editor of the Journal of Clinical Investigation and an editorial board member for Circulation and the Journal of Molecular and Cellular Cardiology. He’s also president of the Association of Professors in Medicine.